Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
CuraWest, situated in Denver, CO, delivers an extensive range of addiction treatment options, including detox and substance abuse rehabilitation. This center features residential detox services along with round-the-clock and short-term residential care designed for both adults and young adults. Emphasizing methods like 12-step facilitation, anger management, and short interventions, CuraWest serves adult men and women, including those who have been affected by domestic or intimate partner violence. By providing tailored care that considers various age groups and genders, they ensure that each client receives a personalized treatment plan, prioritizing high-quality care and ongoing support throughout their journey to recovery.
DISC Village Inc's Wakulla County Human Services site in Crawfordville, Florida, provides outpatient treatment for substance use and co-occurring mental illness with buprenorphine and naltrexone, serving adolescents through seniors including veterans and forensic clients. Medicaid, Medicare, SAMHSA block grants, and sliding fees are accepted.
DISC Village Inc's Leon County Human Services Center in Tallahassee, Florida, offers intensive and regular outpatient treatment for substance use and co-occurring mental illness with buprenorphine and naltrexone, serving all ages including adolescents and veterans. Medicaid, Medicare, SAMHSA block grants, and sliding fees are accepted.
DISC Village Inc's Gadsden County Human Services site in Quincy, Florida, delivers outpatient treatment for substance use and co-occurring mental illness with buprenorphine and naltrexone, covering adolescents through seniors including pregnant women and forensic clients. Medicaid, Medicare, SAMHSA block grants, and sliding fees are accepted.
Long-term residential treatment for women is the focus of DISC Village's Sisters in Sobriety program in Tallahassee, Florida, with transitional housing also available. Programs serve pregnant and postpartum women, veterans, and criminal justice clients. Buprenorphine and naltrexone are used, and Medicaid, Medicare, SAMHSA block grants, and a sliding fee scale are accepted.
Cummins BH Systems Inc, located in Lebanon, IN, specializes in comprehensive outpatient and intensive outpatient services for adults managing substance use disorders alongside co-occurring mental health challenges, as well as for children experiencing significant emotional disturbances. The facility features tailored treatment tracks designed for adolescents, adult men, and adult women. Its therapeutic modalities encompass anger management techniques, brief intervention strategies, and cognitive behavioral therapy. Emphasizing personalized care plans, Cummins BH Systems Inc serves both male and female individuals, offering outpatient medication-assisted treatment options including methadone, buprenorphine, and naltrexone. For those seeking recovery support for themselves or a family member, Cummins BH Systems Inc delivers expert care for adults and young people requiring specialized addiction intervention.
Customized Medical Needs operates partial hospitalization and intensive outpatient programs in Memphis, Tennessee, using buprenorphine and naltrexone and treating co-occurring disorders. Clients include veterans, military families, and criminal justice referrals. Medicare, Medicaid, TRICARE, and a sliding fee scale are accepted.
Situated in Wichita, KS, DCCCA Inc is a rehabilitation center that provides an extensive array of tailored rehabilitation services. The facility offers detoxification, treatment for substance use disorders, and support for individuals facing both substance use issues and serious mental health conditions. With various treatment modalities such as intensive outpatient programs, long-term residential care, and general outpatient services, DCCCA Inc serves both adults and young adults, with particular attention to the needs of older women. This center implements evidence-based methods, including 12-step programs, cognitive behavioral therapy, and contingency management strategies. Additionally, it offers specialized assistance for clients who have suffered from intimate partner violence, domestic abuse, or sexual trauma. DCCCA Inc prioritizes the needs of female clients, fostering a nurturing and inclusive atmosphere ideal for those looking to achieve recovery.
Situated in Lawrence, KS, DCCCA Inc delivers a wide array of rehabilitation services specifically designed for adult women requiring targeted assistance. The center features intensive outpatient care, extended residential options, and outpatient support for adults, seniors, and young adults. With an emphasis on 12-step support, anger management techniques, and brief intervention strategies, this facility focuses on addressing substance use disorders alongside co-occurring mental health issues within a secure and nurturing setting. Additionally, DCCCA Inc provides specialized programs for individuals who have faced intimate partner violence, domestic abuse, or sexual assault, ensuring that each client receives personalized and effective treatment as they embark on their recovery journey.
Situated in Wichita, KS, DCCCA Inc delivers complete recovery support for adult males facing challenges with addiction and concurrent severe mental health conditions. The facility offers diverse care options, encompassing intensive outpatient, extended residential stays, and standard outpatient services. Employing proven methods such as cognitive behavioral therapy and 12-step facilitation, DCCCA Inc is committed to equipping individuals for lasting wellness. Specific offerings are available for those impacted by intimate partner violence, domestic abuse, and sexual trauma. Prioritizing adult males, seniors, and younger men, this establishment guarantees personalized care and assistance throughout each person's path to sobriety.
DCCCA Inc, situated in Pittsburg, KS, delivers thorough substance abuse rehabilitation for adults and young individuals. The facility features intensive outpatient, standard outpatient, and general outpatient treatment plans. Employing scientifically validated methods such as cognitive behavioral therapy, contingency management, and the Matrix Model, this establishment customizes care to meet each person's unique requirements. DCCCA Inc is particularly adept at assisting individuals with a history of trauma, those involved in the legal system, and adolescents. Catering to both men and women, the center is committed to providing high-quality support throughout the recovery journey. For those in search of impactful and individualized addiction therapy, this institution is devoted to fostering enduring sobriety.
Situated in Lexington, KY, DJG LLC delivers a variety of specialized rehabilitation services aimed at individuals in need of substance abuse treatment and transitional housing within a nurturing atmosphere. This center offers intensive outpatient programs, long-term residential treatment, and outpatient services that implement evidence-based strategies including 12-step facilitation, cognitive behavioral therapy, and brief intervention techniques. Focused on personalized care, DJG LLC serves adults, seniors, and young women, particularly addressing the challenges of co-occurring substance use and severe mental health disorders. For those in search of effective care within a structured environment, DJG LLC offers a thorough and empathetic approach to the rehabilitation process.
Situated in Lexington, KY, DJG LLC stands out as a top rehabilitation center focused on treating substance use issues and providing transitional housing for women. The center offers a range of programs, including intensive outpatient, long-term residential, and outpatient options, adopting a holistic approach to recovery that incorporates 12-step support, brief interventions, and cognitive behavioral therapy. DJG LLC is particularly adept at addressing co-occurring substance use disorders alongside serious mental health issues in adults, as well as emotional challenges in children. The center creates personalized treatment plans to cater to the distinct needs of each individual, serving a diverse clientele that includes adults, seniors, and young adults, all within a compassionate and encouraging atmosphere.
Situated in Lexington, KY, DJG LLC provides an extensive array of rehabilitation services focused on addressing substance use disorders, transitional living arrangements, and the treatment of co-occurring substance use issues alongside serious mental health conditions in adults or severe emotional disturbances in children. The center features various treatment modalities, encompassing intensive outpatient care, long-term residential placements, and outpatient services. DJG LLC employs evidence-based methods, including 12-step programs, brief interventions, and cognitive behavioral therapy. Notably, the center is recognized for its customized programs designed specifically for adult women, seniors, and young adults, aiming to facilitate a tailored and effective recovery experience.
Situated in Lexington, KY, DJG LLC delivers a wide range of rehabilitation services aimed at women, seniors, and young adults. This center is dedicated to tackling substance use challenges, providing transitional housing, and addressing co-occurring conditions involving substance use issues alongside significant mental health disorders. DJG LLC offers various treatment options, including intensive outpatient programs, long-term residential care, and outpatient services, ensuring a customized recovery plan for each individual. By employing methods such as 12-step facilitation, brief interventions, and cognitive behavioral therapy, the center prioritizes personalized care. Opt for DJG LLC for a premium rehabilitation journey that focuses on tailored treatment strategies and support for sustainable recovery.
In Lexington, KY, DJG LLC delivers tailored substance abuse recovery services for adult women, older adults, and young adults grappling with concurrent severe mental health conditions. Their offerings encompass intensive outpatient, extended residential stays, and standard outpatient care. These programs are grounded in proven methods like 12-step facilitation, cognitive behavioral therapy, and brief intervention. A key differentiator at DJG LLC is the creation of personalized treatment strategies, customized for the specific requirements of every individual. Prioritizing excellent care and a dedication to comprehensive well-being, this establishment fosters a nurturing atmosphere for those pursuing healing from addiction and mental health struggles.
Situated in Lexington, KY, DJG LLC provides complete care for individuals battling substance use issues, alongside transitional living options for adult women. This establishment is adept at addressing dual diagnoses of substance use disorders and significant mental health conditions in adults, along with severe emotional challenges in children. The center offers a range of services including intensive outpatient, extended residential stays, and general outpatient programs, utilizing methods like 12-step facilitation, brief interventions, and cognitive behavioral therapy. Emphasizing personalized attention, DJG LLC serves adults, older adults, and young adults looking for a customized recovery journey. Discover exceptional, individualized support at this location.
DJG LLC, located in Lexington, KY, provides a full spectrum of recovery assistance for adults, older individuals, and young adults. Their expertise lies in addressing addiction, offering stable living accommodations, and treating individuals facing both substance abuse challenges and mental health conditions, including serious psychiatric disorders and emotional distress. The center offers intensive outpatient, extended residential, and standard outpatient services. Prioritizing personalized support, they incorporate methods such as 12-step encouragement, short-term counseling, and cognitive restructuring techniques. DJG LLC distinguishes itself by offering dedicated programs for women, fostering a secure and gender-sensitive atmosphere for healing. Expect exceptional service and custom-designed recovery strategies at this center.
In Lexington, KY, DJG LLC provides extensive care for substance use issues, catering to women of all ages, from young adults to seniors. The center excels in addressing dual diagnoses, managing concurrent substance use and significant mental health conditions in adults, as well as serious emotional disturbances in children. DJG LLC offers a spectrum of treatment options, from intensive outpatient programs to extended residential stays, ensuring personalized support through methods such as 12-step facilitation, cognitive behavioral therapy, and brief intervention strategies. Their distinct emphasis on a personalized care model guarantees that each client receives treatment specifically designed for their needs. For reliable rehabilitation services within a nurturing setting, DJG LLC is a recommended choice.
DM Consultants, situated in Southfield, MI, provides a full spectrum of recovery assistance. This establishment focuses on addiction treatment, temporary accommodation, and care for individuals facing both substance abuse and significant mental health conditions. Offering extended stay residential, outpatient, and round-the-clock residential choices, the center serves adults and younger adults. DM Consultants features distinct programs for adult men and women, along with those who have endured sexual trauma. Their scientifically supported methods, encompassing anger control, rapid counseling, and motivational rewards, guarantee superior support for those pursuing healing.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.